Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
About this episode
Dr Andrew J Armstrong and Dr Scott T Tagawa discuss therapy selection and recent advances in prostate cancer treatment.
Dr Andrew J Armstrong from the Duke Cancer Institute in Durham, North Carolina, and Dr Scott T Tagawa from Weill Cornell Medicine Meyer Cancer Center in New York, New York, discuss the selection and sequencing of therapy for patients with prostate cancer and summarize major advances in the treatment landscape over the past year. CME information and select publications here .
More episodes of Oncology Today with Dr Neil Love
- EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
- Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
- Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
- HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
- Metastatic Bladder Cancer — Rapid Case Review Issue 4
Explore listener stats, chart rankings, contacts and more on the Oncology Today with Dr Neil Love podcast page.